Intracranial Atherosclerosis Epidemiology Forecast 2026-2035

Intracranial atherosclerosis is a major contributor to global stroke burden. As per Han Yan et al., 2024, intracranial atherosclerotic stenosis accounts for 33%-50% of ischemic strokes in Asians, 15%-29% in Africans, and 5%-10% in Europeans. According to intracranial atherosclerosis epidemiology forecast, the disease is among the leading causes of cerebrovascular events worldwide, and the burden is expected to rise steadily.

Intracranial Atherosclerosis Epidemiology Forecast Report Coverage

The analyst's “Intracranial Atherosclerosis Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of intracranial atherosclerosis. It projects the future incidence and prevalence rates of intracranial atherosclerosis cases across various populations. The study covers age, gender, and type as major determinants of the intracranial atherosclerosis population. The report highlights patterns in the prevalence of intracranial atherosclerosis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of intracranial atherosclerosis in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Intracranial Atherosclerosis Understanding: Disease Overview

Intracranial atherosclerosis is a cerebrovascular condition characterized by the buildup of atherosclerotic plaques within the arteries of the brain. It occurs due to lipid accumulation, inflammation, and endothelial dysfunction, leading to narrowing (stenosis) or blockage of intracranial vessels. This process reduces cerebral blood flow and increases the risk of ischemic stroke or transient ischemic attacks. The disease is commonly classified based on the degree of arterial stenosis (mild, moderate, or severe) and the specific arteries involved, such as the middle cerebral or basilar arteries.

Intracranial Atherosclerosis Epidemiology Perspective

The intracranial atherosclerosis epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the intracranial atherosclerosis epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for intracranial atherosclerosis and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• As per the Radiopaedia, intracranial atherosclerotic disease is a major global cause of ischemic stroke, particularly in Asians, where it accounts for up to 50% of cases, while contributing to approximately 10-12% of strokes in Caucasian populations.
• According to Liv-Hege Johnsen et al., 2023, prevalence varies significantly by study type, with autopsy data showing 43% in French fatal stroke cases and 31.4% in Chinese cases, while imaging-based studies report 12.1% prevalence among Caucasians with transient ischemic attack or ischemic stroke.
• As per population-based findings cited by Liv-Hege Johnsen et al., 2023, prevalence in the general population ranges from 4.7% to 15.7% in Asians, approximately 8% in Caucasians from the Atherosclerosis Risk in Communities study, and 3.3% for significant stenosis in asymptomatic European cohorts.
• According to Liv-Hege Johnsen et al., 2023, age-wise distribution shows a marked increase, with a 15-fold higher prevalence in individuals aged 75-84 years compared to 40-54 years, with a mean cohort age of 63.8 years and a slight female predominance of 53.2%.
• As per Lainelehto et al., 2024, mortality remains high, with an 18% cumulative three-year death rate, 58% two-year survival after first stroke due to large-artery atherosclerosis, and up to 2.3-fold increased long-term mortality risk compared to patients without atherosclerosis.

Country-wise Intracranial Atherosclerosis Epidemiology

The intracranial atherosclerosis epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Epidemiological patterns of intracranial atherosclerosis demonstrate notable regional variation across major healthcare markets. According to Charles Beaman et al., 2022, intracranial atherosclerotic disease accounts for nearly 10% of ischemic strokes in the United States, while contributing to up to 50% of stroke burden across Asia, including India and Japan. As per Li Hui Chen et al., 2024, asymptomatic prevalence with ≥50% stenosis is estimated at 6% in Japan, 11% in the United Kingdom, and 9% in Spain, with variations driven by study populations and diagnostic approaches; comparable structured epidemiological data for Germany, France, Italy, and India remain limited but indicate rising burden aligned with vascular risk profiles.

Intracranial Atherosclerosis: Treatment Overview

Management of intracranial atherosclerosis focuses on reducing stroke risk and improving blood flow. First-line treatment includes aggressive medical therapy with antiplatelet agents (such as aspirin or clopidogrel), statins for lipid control, and strict management of risk factors like hypertension and diabetes. Lifestyle modifications, including smoking cessation and dietary changes, are essential. In selected high-risk cases with severe stenosis, endovascular interventions such as angioplasty and stenting may be considered. Surgical options are less common but may be used in refractory cases under specialized clinical settings.

Key Questions Answered

• What are the key findings of intracranial atherosclerosis epidemiology in the 8 major markets?
• What will be the total number of patients with intracranial atherosclerosis across the 8 major markets during the forecast period?
• What was the country-wise intracranial atherosclerosis epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of intracranial atherosclerosis patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of intracranial atherosclerosis during the forecast period of 2026-2035?
• What are the currently available treatments for intracranial atherosclerosis?
• What are the disease risks, signs, symptoms, and unmet needs of intracranial atherosclerosis?

Scope of the Intracranial Atherosclerosis Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of intracranial atherosclerosis based on several factors.
• Intracranial Atherosclerosis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The intracranial atherosclerosis report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.